Supporting Methods
Cloning and mutagenesis. Plasmids encoding for Cerulean and Citrine, connected via a long (GGSGGS) 9 linker, containing different (Cys) 4 binding pockets were synthesized in previous research.
A QuikChange Multi Site-Directed mutagenesis (Agilent Technologies) was used to simultaneously introduce different combinations of C144H and C206H mutants in pET28a-eZinCh-4 (primers 1&2 and 3&4 for mutating C144H and C206H, respectively, Supplementary Table 1 ), generation pET28a-eZinCh-2.1.
Vector pET28a-eZinCh-5 was used to introduce combinations of C206H and C208H mutations by using primer 5&6 and 7&8, respectively, yielding pET28a-eZinCh-2.2, pET28a-eZinCh-2.3 and pET28a-eZinCh-2.4.
To create the mammalian expression vector of one of the eZinCh mutants (pET28a-eZinCh-2), pET28a-eZinCh-2 was digested with Nde I and Not I to obtain a fragment encoding for eZinCh-2 that could be ligated into a Nde I/ Not I digested peCALWY-4 vector to yield the mammalian expression vector peZinCh-2 1 . For ER-targeting a pcDNA3.1 vector containing the Preproinsulin (PPI) signal peptide, cerulean and citrine fused by a nine GGSGGS linker and a four amino acid long retention sequence KDEL at the end of the C-terminus was ordered (Genscript, USA). For mitochondrial targeting a Not I restriction site was introduced in the pShuttle-mito-eCALWY-4 by site directed mutagenesis (Agilent Technologies). Next pET28a-eZinCh-2 was digested with Age I and Not I to obtain a part of the fragment encoding for eZinCh-2 that could be ligated into a Age I/ Not I digested pShuttle-mito-eCALWY-4 vector, yielding pShuttle-mito-eZinCh-2. To create the vesicle-targeted mammalian expression plasmid, pET28a-eZinCh-2 was digested with Age I and Protein expression and purification. E. coli BL21(DE3) transformed with expression plasmid was grown to OD600 in 500 mL Lysogeny Broth (LB) medium containing 50 μg/mL kanamycin in a shaking incubator at 37 °C. Following induction with 0.1 mM IPTG, the bacterial cultures were grown overnight at 25 °C in a shaking incubator at 250rpm. Cells were harvested by centrifugation and lysed using 10 mL BugBuster Protein Extraction reagent (Novagen) with 10 μL Benzonase.
Proteins were purified by Ni-NTA affinity chromatography. Since His-tags are known to readily bind Zn 2+ , they were removed from all constructs using thrombin cleavage. After elution from the Ni-NTA column, the buffer was exchanged to thrombin cleavage buffer (20 mM Tris-HCl (pH 8.4), 150 mM NaCl, 2.5 mM CaCl2) using PD10 desalting columns (GE, Healthcare). Cleavage of the thrombin recognition site between the His-tag and the Cerulean N-terminus was initiated by the addition of 0.3 U thrombin protease (Novagen) per mg target protein at a 0.2 mg/mL target protein concentration.
Cleavage was carried out at RT for 20 hours, after which 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma) was added to inactivate the thrombin enzyme. Proteins were then loaded onto Ni-NTA once again. To separate the cleaved and uncleaved protein and also the His-tags remained behind on the Ni-column. Subsequently the proteins were loaded onto a size exclusion column (Sephacryl S200, GE Healthcare), using a buffer containing 50 mM Tris, 100 mM NaCl, 4 M Urea and 5 mM DTT. The SEC fractions were analyzed by SDS PAGE for correct size and purity, pooled and concentrated using 10 kDa MWCO centrifugation filters.
Co-localization experiments.
HeLa cells were seeded on coverslips and transfected with plasmids encoding for either ER-eZinCh-2 or mito-eZinCh-2 using Lipofectamine 2000. Proteins were allowed to over express for ~24 h. Cells were washed with HBSS buffer, and stained with 1 µM ER-Tracker Red (Life Technologies) or 300 nM MitoTracker Red (Life Technologies) for 30 min. Cells were imaged on the Leica, TCS SP5X, using the 63x water immersion objective. The expressed eZinCh-2 was excited using the 405 nm laser, followed by recording emission between 515-595 nm. The commercial available ER and Mito Tracker were excited around 587 nm and 581 nm, followed by recording the emission between 605 -625 nm and 630 -660 nm, respectively.
For immunocytochemical analysis, INS1(832/13) cells expressing VAMP2-eZinCh2 were fixed in paraformaldehyde 4% for 20 minutes, permeabilized with Triton X-100 (0.5%) for 25 minutes, and S4 probed with primary antibody against insulin (1:100, DAKO, Cambridgeshire, U.K.), then visualised with Alexa Fluor 568 secondary antibodies (1:200; Life Technologies). Specimens were mounted on glass slides using Vectashield hard set (Vector Laboratories). Image acquisition was performed with a Zeiss Axiovert microscope coupled to a Nipkow spinning-disk head (Yokogawa CSU-10) using a 63x/NA1.4 objective. Two solid-state lasers (CrystaLaser) controlled by a laser-merge module (Spectral Applied Physics) provided wavelengths of 491 nm to excite VAMP2-eZinCh2.2 and 561 nm for insulin. Emitted light was filtered at 525/50 nm and at 630/50nm, respectively. Images were captured with a highly sensitive 16-bit, 512 × 512 pixel back-illuminated EM-CCD camera (ImageEM 9100-13; Hamamatsu).
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Supporting Table 1 : Sensor properties of the eZinCh mutants at pH 7.1. 
Mutants
Primer Sequence 1 5'-CACAAGCTGGAGTACCACGCCATCAGCGACAAC-3' 2 5'-CTGGGGCACAAGCTTGAGTACCACTACAACAGCCACAAC-3' 3 5'-CTGAGCACCCAGTCCCACCTGAGCAAAGACCCCAAC-3' 4 5'-CTGAGCTACCAGTCCCACCTGAGCAAAGACCCCAAC-3' 5 5'-CTGAGCACCCAGTCCTGCCTGCACAAAGACCCCAACGAG-3' 6 5'-CTGAGCTACCAGTCCTGCCTGCACAAAGACCCCAACGAG-3' 7 8 5'-CTGAGCACCCAGTCCCACCTGTGCAAAGACCCCAACGAG-3' 5'-CTGAGCTACCAGTCCCACCTGTGCAAAGACCCCAACGAG-3'
G S S H H H H H H S S G L V P R G S H 61
atggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggac 120 atataagcagagctggtttagtgaaccgtcagatccgctagcgccgccaccatgggccat 60 
